HARP(Delisted)
Harpoon TherapeuticsยทNASDAQ
--
--(--)
HARP fundamentals
Harpoon Therapeutics (HARP) released its earnings on Mar 14, 2019: revenue was -- (YoY 0.00%), beat estimates; EPS was -- (YoY 0.00%), met estimates.
Revenue / YoY
--
0.00%
EPS / YoY
--
0.00%
Report date
Mar 14, 2019
EPS
Revenue
Revenue & Expenses
HARP has released its 2023 Q3 earnings report, with revenue of 4.45M, reflecting a YoY change of -67.33%, and net profit of -1.80M, showing a YoY change of 84.52%. The Sankey diagram below clearly presents HARP's revenue sources and cost distribution.
Key Indicators
Harpoon Therapeutics (HARP) key financial stats and ratios, covering profitability, financial health, and leverage.
Harpoon Therapeutics (HARP)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Harpoon Therapeutics (HARP)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Harpoon Therapeutics (HARP)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Harpoon Therapeutics (HARP) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Harpoon Therapeutics (HARP) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
No Data
